MedPath

The Effect of Electronic Cigarette Use on Smoking Behaviors Among Smokers Receiving Outpatient Psychiatric Treatment

Not Applicable
Recruiting
Conditions
Tobacco Smoking
Psychiatric Disorders
Interventions
Other: E-cigarette
Registration Number
NCT04014322
Lead Sponsor
Fordham University
Brief Summary

This study aims to establish the feasibility and acceptability of a project designed to investigate the impact of electronic cigarette use on combustible cigarette smoking and smoking-related factors among smokers with psychiatric disorders, a high-risk population, who are not yet ready to quit smoking. All participants will be instructed to switch completely from combustible cigarettes to e-cigarettes for the next 8 weeks. They will be assessed at baseline, 2 weeks, 4 weeks, 8 weeks and 12 weeks.

Detailed Description

In recent years, the prevalence of e-cigarette use has rapidly increased, especially among those with psychiatric conditions, and the risks and potential benefits of e-cigarette use have been the topic of much debate. More research is needed to understand the impact of e-cigarette use on smoking behavior and smoking-related cognitions among individuals with psychiatric conditions.

This study will investigate the effects of e-cigarette use on cigarette smoking and motivation/readiness to quit among smokers with psychiatric disorders who are not yet ready to quit smoking. A total of 50 adult daily cigarette smokers who are receiving outpatient psychiatric treatment and not yet ready to quit smoking will be recruited. All participants will be instructed to switch completely from combustible cigarettes to e-cigarettes for the next 8 weeks. E-cigarettes will be provided to participants at no cost. Participants will also be asked to complete 5 (remote and in-person) assessment sessions (i.e., baseline, 2-week, 4-week, 8-week and 12-week follow-ups).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • 21 years of age or older
  • English-speaking,
  • current daily smokers (i.e., at least 5 cigarettes/day)
  • have been daily smokers at least for 6 months
  • attended a minimum of 2 treatment visits in the past 12 months at Montefiore Behavioral Health Center
  • have at least one psychiatric disorder (other than substance use disorders),
  • willing to try switching to use e-cigarettes (provided by the research team) exclusively for a total of 8 weeks,
  • those who are not yet ready to quit smoking,
  • for women of childbearing age, willingness to use contraception during the study.
Exclusion Criteria
  • acute psychiatric symptomatology which precludes study participation including current active suicidal ideation
  • current diagnosis of dementia or cognitive impairment sufficient to impair provision of informed consent or study participation
  • patient's inability to provide consent for study participation due to his/her inability to demonstrate an understanding of study procedures as contained in the statement of informed consent, after no more than two explanations
  • current clinical diagnosis of intellectual development disorder
  • current regular use of other tobacco products or combustible marijuana
  • current (non-nicotine) substance use disorder and current substance use (in the past month)
  • current effort to quit smoking or current use of pharmacotherapy (in the past month) to quit smoking,
  • pregnant, breastfeeding, or planning to become pregnant within 6 months, current unstable cardiovascular disease,
  • current unstable pulmonary disease (i.e., an ER visit or hospitalization due to pulmonary issues in the past 6 month or current use of oxygen therapy),
  • patient does not have a stable home address where the research team could reliably reach patient
  • household members are currently participating or have participated in this research study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
E-cigaretteE-cigaretteAll participants will be instructed to switch completely from combustible cigarettes to e-cigarettes for the next 8weeks. They will be assessed at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks.
Primary Outcome Measures
NameTimeMethod
Changes in the number of combustible cigarettes smoked per dayBaseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks

The average number of cigarettes smoked per day

Changes in Carbon Monoxide LevelBaseline,2 weeks, 4 weeks, 8 weeks, 12 weeks

Changes in Carbon monoxide level measured with a breath carbon monoxide monitor

Rates of those who completely switched to e-cigarettesBaseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks

Rates of those who completely switched to e-cigarettes

Changes in Nicotine DependenceBaseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks

Fagerstrom Test of Cigarette Dependence

Changes in the use of e-cigarettesBaseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks

Changes in the use of e-cigarettes

Secondary Outcome Measures
NameTimeMethod
Changes in Withdrawal SymptomsBaseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks

Minnesota Nicotine Withdrawal Scale

Changes in Motivation/Readiness to Quit SmokingBaseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks

Thoughts about Abstinence Scale \& Contemplation Ladder

Trial Locations

Locations (1)

Montefiore Behavioral Health Center

🇺🇸

Bronx, New York, United States

© Copyright 2025. All Rights Reserved by MedPath